MAPKAPK2 hotspots were shared across three entities, namely breast carcinoma (7 of 644 tumors), head and neck squamous cell carcinoma (3 of 56 tumors) and cervical squamous cell carcinoma (1 of 18 tumors). The gene discussed is MAPKAPK2; the disease is head and neck squamous cell carcinoma.